We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Rewriting Life

Personal Genomes

Individual sequencing could be around the corner.

The Human Genome Project’s working draft sequence, which was completed to much fanfare in June 2000, took about a dozen years and more than $300 million to complete. The result was a composite map of the DNA from several people-a sort of averaged genetic picture of a human. But a growing number of companies are working on advanced technologies that could make it possible to have your own individual genome sequenced in a day, perhaps for as little as a few thousand dollars.

No one’s genetic makeup matches “the human genome” exactly; the differences are what give one person brown eyes and another blue or make some people more susceptible to heart disease. The new technologies could give anyone access to the unique, letter-by-letter sequence of his or her entire genome and help doctors detect the variations that signal health problems down the road.

Today’s sequencing methods are costly and slow in part because for each DNA letter read-of the roughly three billion in a human genome-researchers need to synthesize a separate copy of the DNA strand. Making the copies requires several chemical reactions; then you have to separate and identify the newly made strands. In contrast, two new techniques being developed could read the sequence directly from one DNA molecule. The first method, called “nanopore sequencing,” involves pushing a strand of DNA through a tiny hole surrounded by sensors that detect the electrical changes caused by each DNA letter. The second takes advantage of an enzyme called DNA polymerase, which copies DNA inside our cells. Researchers use specialized optics to detect each letter added as the enzyme copies the original DNA strand.

This story is part of our October 2001 Issue
See the rest of the issue

In May, Palo Alto, CA-based Agilent Technologies signed an agreement with Harvard researchers Daniel Branton and Jene Golovchenko to further develop nanopore sequencing, which Branton coinvented (see “Hole in the Wall Offers Cheaper Sequencing,” TR May/June 1998). Also this year, Woburn, MA-based U.S. Genomics received its first patents on technologies that combine the two direct techniques. Thanks to these and several other efforts (see table), the dream of sequencing a human genome in just a day could be a reality in two to five years, says George Weinstock, codirector of the Baylor College of Medicine Human Genome Sequencing Center in Houston. “They’re all very clever techniques,” he says. “We’re getting very close to having them in hand.”

Though the new sequencing tools will initially be used for biomedical research, they could eventually find their way into doctors’ offices, not only providing for quick gene-based diagnosis of a host of diseases, but also helping doctors choose medicines tailored to individual patients. The expected price tag to sequence your genome-perhaps $5,000 to $30,000-might seem steep, but “it’s kind of a life investment,” says Harvard Medical School biophysicist George Church. “I would pay $10,000 to get my genome sequencedrather than buying a second car.”

Cut off? Read unlimited articles today.

Become an Insider
Already an Insider? Log in.

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Online Only.
  • Insider Online Only {! insider.prices.online !}*

    {! insider.display.menuOptionsLabel !}

    Unlimited online access including articles and video, plus The Download with the top tech stories delivered daily to your inbox.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.